Published: 06/24/2022 10:47 GMT Emergent Biosolutions Inc (EBS) - Emergent Biosolutions Announces FDA Acceptance of Biologics License Application for Av7909 Anthrax Vaccine Candidate.
Emergent Biosolutions Inc- Prescription Drug User Fee Act Goal Date for a Decision by FDA is in April 2023.